The Minister of Health, Alexandre Padilha, announced this Sunday (18) that around 1.1 million public health professionals in the country will be able to be immunized against dengue from February 9th.
The vaccine used in the campaign will be Butantan-DV, developed by the Butantan Institute with 100% national technology. This is the first single-dose vaccine against dengue in the world.
The minister also explained that vaccinating this public will be possible with the arrival of more doses of the vaccine. The Butantan Institute must produce and deliver, by January 31, around 1.1 million additional doses of the vaccine, with the aim of immunizing professionals working on the front lines of the Unified Health System (SUS).
Butantan-DV antibodies offer protection against the four serotypes of the dengue virus. Clinical studies indicate an overall efficacy of 74% for the Brazilian vaccine, with a 91% reduction in severe cases and 100% protection against hospitalization for the disease transmitted by the Aedes aegypti mosquito.
